Baylor Dallas News

Pink Passion® Shoe Decorating Contest Winners to be Named at Fashion Show Oct. 17

(DALLAS, TEXAS, Oct. 7, 2009) – Shoes decked out in pink, teal and lots of bling will be stealing the spotlight at the Pink Passion® Fashion Show at 2 p.m. on Oct. 17 at Saks Fifth Avenue Galleria Dallas. Sponsored by the Baylor Charles A. Sammons Cancer Center at Dallas and Saks, the purpose of the annual Pink Passion Shoe Design and Decorating Contest is to raise awareness about breast and ovarian cancer. The fashion show is free.

Entrants were encouraged to use their creativity to show support for those battling breast and ovarian cancer. The public is invited to vote for their favorite shoes online at BaylorHealth.com/PinkPassion Oct. 12 – 16. First and second place winners will be named in the Adult category, and a first place winner will be named in the Kids 12 and Under category.

The top 20 shoe finalists will be on display at the Pink Passion Fashion Show, which will feature breast and ovarian cancer survivors modeling 2009 fall fashions and female physician specialists discussing the facts on women’s cancers. The shoes will then be on display at Baylor University Medical Center at Dallas Oct. 19 – 31.

The Link Between Breast, Ovarian Cancer

Breast cancer and ovarian cancer often go hand-in-hand when it comes to an increased risk of developing either cancer. Their relationship is rooted in hereditary factors. Studies make it clear that women with a family history or breast cancer or ovarian cancer have an increased risk of developing either disease. 

For many cases of breast and ovarian cancer, their partnership is rooted in two genes: BRCA1 and BRCA2. A woman’s lifetime chance of developing breast and/or ovarian cancer is greatly increased when these genes are altered, according to the National Cancer Institute (NCI).

About Baylor Charles A. Sammons Cancer Center at Dallas

All forms of cancer are treated at the Baylor Charles A. Sammons Cancer Center, with particular emphasis on cancers of the breast, prostate, lung, colon, and gynecologic cancers, as well as hematologic malignancies (leukemia, lymphoma and myeloma). Through research underway at Baylor Research Institute, Texas Oncology, U.S. Oncology and the Mary Crowley Cancer Research Centers, the cancer center offers patients access to more than 150 national clinical trials and innovative cancer treatments.

The expansion of the Baylor Charles A. Sammons Cancer Center includes a new outpatient cancer center which will open in early 2011and will transform the cancer program into North Texas’ first dedicated cancer hospital.